Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

Rexista’s Blue Dye Will Never Get Past AdComm



No Advantage + Possible Side Effects --> Hindenburg




http://www.fiercebiotech.com/biotech/19-1-vote-fda-panel-rejects-acurox

In 19-1 vote, FDA panel rejects Acurox
“What I'm hearing from the committee is that it's probably not appropriate to put the niacin in this product because it does not have a definitive advantage, and it has associated side effects," said Jeffrey Kirsch, chairman of the Anesthetic and Life Support Drugs Advisory Committee, which voted on the drug.

IF the NDA gets filed and IF it is accepted, Rexista goes down big at AdComm. Dr. Odidi knows it, and so does Big Pharma.